mRNA Cancer Therapy Boosts Immune Response

An investigational, individualized neoantigen therapy, with personalized encoded mRNA, has demonstrated potential to enable patients’ immune systems to target cells that cause cancer.

Innovations in Bioidentical Hormone Replacement Therapy

Touted as a more natural approach to hormone replacement therapy, this plant-based anti-aging remedy has evolved from an unregulated safety concern to a mainstay of modern medicine.

Advances in Treating Menopause

Menopause is a normal, natural event in every woman’s life, but it can cause a variety of uncomfortable symptoms. New therapies show promise for bringing relief and an improved quality of life.

How Gene Therapy Is Curing Diseases

For patients with genetic disease, recent evolution of and FDA approval for gene therapies are transforming care and turning an ambitious dream into a life-changing reality. But getting affordable treatments to patients safely and efficiently remains a challenge.

Next-Generation Primary Care: How “Going to the Doctor” Is Changing

The future of healthcare is being driven by digital transformations and emerging technology that provide preventive, personalized and predictive medicine.

Scientists Develop $25 Nasal Spray That Is 99% Effective Against Colds, Flu and COVID-19

Scientists at Harvard Medical School have developed a simple nasal spray, made of harmless ingredients, that can protect people against flu, colds and COVID-19 with near-100 percent success, and it costs just $25.

Immune Globulin and Prophylactic Antibiotics Provide Similar Efficacy in Treating Hypogammaglobulinemia Secondary to Hematological Malignancy

Immune globulin replacement and prophylactic antibiotics are commonly used to prevent infections in patients with secondary hypogammaglobulinemia due to hematological malignancies but have never been directly compared. 

Update on Treating Neutropenia

While neutropenia can be a life-threatening condition, physicians have many tools to treat it.

New Vaccine Could Lower ‘Bad’ Cholesterol by as Much as 30 Percent

A new vaccine currently in development can effectively and affordably lower levels of “bad’ cholesterol in the body, a health problem that affects almost two in five adults in the U.S.

World’s First Gene Therapies Approved to Treat Sickle Cell Disease

The U.S. Food and Drug Administration has approved two treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years and older.